chr1-219981426-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_004446.3(EPRS1):c.3405G>A(p.Gln1135=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 1,602,576 control chromosomes in the GnomAD database, including 97,780 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.35 ( 9512 hom., cov: 32)
Exomes 𝑓: 0.35 ( 88268 hom. )
Consequence
EPRS1
NM_004446.3 synonymous
NM_004446.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.66
Genes affected
EPRS1 (HGNC:3418): (glutamyl-prolyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases are a class of enzymes that charge tRNAs with their cognate amino acids. The protein encoded by this gene is a multifunctional aminoacyl-tRNA synthetase that catalyzes the aminoacylation of glutamic acid and proline tRNA species. Alternative splicing has been observed for this gene, but the full-length nature and biological validity of the variant have not been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.23).
BP6
Variant 1-219981426-C-T is Benign according to our data. Variant chr1-219981426-C-T is described in ClinVar as [Benign]. Clinvar id is 1166606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.66 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.381 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPRS1 | NM_004446.3 | c.3405G>A | p.Gln1135= | synonymous_variant | 24/32 | ENST00000366923.8 | NP_004437.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPRS1 | ENST00000366923.8 | c.3405G>A | p.Gln1135= | synonymous_variant | 24/32 | 1 | NM_004446.3 | ENSP00000355890 | P1 |
Frequencies
GnomAD3 genomes AF: 0.354 AC: 53761AN: 151690Hom.: 9496 Cov.: 32
GnomAD3 genomes
AF:
AC:
53761
AN:
151690
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.346 AC: 86312AN: 249560Hom.: 15186 AF XY: 0.340 AC XY: 45868AN XY: 134944
GnomAD3 exomes
AF:
AC:
86312
AN:
249560
Hom.:
AF XY:
AC XY:
45868
AN XY:
134944
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.346 AC: 502575AN: 1450780Hom.: 88268 Cov.: 31 AF XY: 0.345 AC XY: 248829AN XY: 721638
GnomAD4 exome
AF:
AC:
502575
AN:
1450780
Hom.:
Cov.:
31
AF XY:
AC XY:
248829
AN XY:
721638
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.355 AC: 53823AN: 151796Hom.: 9512 Cov.: 32 AF XY: 0.351 AC XY: 26038AN XY: 74162
GnomAD4 genome
AF:
AC:
53823
AN:
151796
Hom.:
Cov.:
32
AF XY:
AC XY:
26038
AN XY:
74162
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1176
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Leukodystrophy, hypomyelinating, 15 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at